Approved Study Database

Ref. No. Scientific Title Principal investigator
2011.429 Alcohol Related Liver Damage in Hong Kong Prof. Chan Lik Yuen, Henry
2011.135 Establishment of Specimen Bank for Hepatology Research Prof Chan Lik Yuen Henry
2013.115 An Open Label, Phase 2a, Single-Arm Study of the Antifibrotic Activity of FG-3019 in Subjects with Advanced Liver Fibrosis due to Chronic Hepatitis C Infection (HCV) Prof Chan Lik Yuen Henry
2012.536 A multicenter open-label study to evaluate the safety and efficacy of PEG-Intron™ versus PEGASYS™ in subjects with HBeAg positive chronic hepatitis B and HBeAg negative chronic hepatitis B Prof. Chan Lik Yuen Henry
2012.046 Serum hepatitis B surface antigen levels to guide the stopping of entecavir in HBeAg-negative chronic hepatitis B Prof Chan Lik Yuen Henry
2017.177 A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Switching from Tenofovir Disoproxil Fumarate (TDF) 300 mg QD to Tenofovir Alafenamide (TAF) 25mg QD in Subjects with Chronic Hepatitis B who are Virologically Suppressed Dr. CHAN Lik Yuen
陳力元
2015.124 A MULTIPLE-CENTER, RANDOMIZED, PARTIALLY DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS AND ANTIVIRAL EFFECTS OF 12-WEEK TREATMENT WITH RO6864018 IN VIROLOGICALLY SUPPRESSED PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION Prof. CHAN Lik Yuen
陳力元
2017.328 A PHASE I, SPONSOR-OPEN, INVESTIGATOR-BLINDED, SUBJECT-BLINDED, MULTI-CENTER, PLACEBO-CONTROLLED STUDY TO EVALUATE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL ADMINISTRATION OF RO7020531: (1). SINGLE AND MULTIPLE ASCENDING DOSES IN HEALTHY MALE AND FEMALE SUBJECTS; (2). 6-WEEK TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION Prof. CHAN Lik Yuen
陳力元
2016.089 A MULTIPLE-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-ASCENDING DOSE AND MULTIPLE-ASCENDING DOSE, ADAPTIVE PARALLEL STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF RO7020322 FOLLOWING ORAL ADMINISTRATION IN HEALTHY SUBJECTS AND CHRONIC HEPATITIS B PATIENTS Dr. CHAN Lik Yuen
陳力元
2008.168 A Functional Study of An Epithelial-Mesenchymal Transition Regulatory Transcription Factor Snail in Prostate Cancer Prof. Chan Leung Franky
2010.579 Functional roles of an orphan nuclear receptor Tailless TLX in advanced prostate cancer Prof CHAN Leung Franky
2013.138 Orphan nuclear receptor estrogen-related receptor alpha (ERRa): functional roles and potential therapeutic targeting in hormone-dependent and -independent prostate and breast cancers Professor Chan Leung Franky
2015.512 Effect of a structured aerobic exercise programme in managing fatigue among community dwelling older adults with multicomorbidities by a prospective randomized controlled trial Mr. CHAN Leong Tat
陳亮達
2014.626 Evaluation of the psychometric properties of the Chinese version of the Multidimensional Fatigue Inventory among community dwelling older adults with multicomorbidities by a non-experimental, prospective, descriptive, correlation study design Mr Chan Leong Tat
2019.175 Variation in intensive care practices for moderate to severe traumatic brain injury Dr. CHAN Lawrence Chi Ngong
陳子昂
2017.533 Prevalence of neuromyelitis optica in Hong Kong Dr. CHAN Larry Wai Lun
陳偉麟
2024.311 Stereotactic Body Radiotherapy and Atezolizumab plus Bevacizumab in Advanced Hepatocellular Carcinoma with Major Portal Vein Thrombosis Dr Chan Landon
2011.145 The use of circulating methylated RASSF1A in prognostication and monitoring of treatment response for inoperable hepatocellular carcinoma Dr. Chan Lam, Stephen
2010.563 An open-label, randomized, multi-center, phase II study to compare the safety and efficacy of TKI258 versus sorafenib as first-line treatment in adult patients with advanced hepatocellular carcinoma Assistant Professor Chan Lam, Stephen
2024.253 A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 193 in Combination With other Therapies in Subjects With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous MTAP-deletion – Master Protocol Professor CHAN Lam Stephen
2024.098 Establishment of a Hepatocellular Carcinoma Database Prof Chan Lam Stephen
2010.564 A Randomized Phase III study of Oxaliplatin (Eloxatin) and Capecitabine on top of Sorafenib versus Sorafenib alone as first-line palliative treatment in advanced hepatocellular carcinoma patients ineligible for curative resection or local treatment Prof Chan Lam
2016.085 A Phase 3 Randomized, Open-Label Study Comparing Pexa-Vec (Vaccinia GM CSF / Thymidine Kinase-Deactivated Virus) Followed by Sorafenib Versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma (HCC) Without Prior Systemic Therapy Dr. CHAN Lam
陳林
2015.459 A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Enzalutamide in Subjects with Advanced Hepatocellular Carcinoma Prof. CHAN Lam
陳林
2011.529 Effectiveness of warm lignocaine in reducing infiltration pain during digital nerve block injection: A randomized controlled trial. Ms CHAN LAI MAN
2008.430 Comparison of the Accuracy of Bernese Ankle Rules and Ottawa Ankle Rules in Ruling Out Ankle and Mid-Foot Fractures of Adults in Twisting Ankle and Foot Injury. A Prospective Cross Sectional Study Ms CHAN LAI MAN
2012.508 Psychiatric and physical comorbidities among primary care insomniacs in Hong Kong Dr. Chan Kwok Keung
2008.166 Investigationof the Genomic Representation of Fetal DNA in the Plasma of Pregnant Women Prof CHAN Kwan Chee Allen
2010.021 Investigation into the association between the presence of methylate tumour suppressor gene sequences in serum and the risk of developing hepatocellular carcinoma in chronic hepatitus B carriers Prof CHAN Kwan Chee Allen
2011.106 Molecular characterization of circulating DNA in nasopharyngealcarcinoma patients Prof Chan Kwan Chee Allen
2009.472 Molecular anaylsis of plasma DNA of nasopharyngeal carcinoma patients Prof CHAN Kwan chee Allen
2008.024 Investigation on the Long and Short-term Variations of Plasma Epstein-Barr Virus (EBV) DNA in Healthy Subjects Prof Chan Kwan Chee Allen
2013.284 Detection of Cerebral Autoregulation in Patients witih Supertentorial Intracerbral Hemorrhage Using Transcranial Doppler Ultrasonography DR CHAN KIT YING
2012.433 Retrospective study on the incidence of cleft palate and the outcome of cleft palate repair Dr Chan Kin Wai Edwin
2013.148 Retrospective study on the management in children with anorectal malformation Dr Chan Kin Wai Edwin
2014.152 Retrospective study on the outcome of Kasai portoenterostomy in infant with biliary atresia Dr Chan Kin Wai Edwin
2023.115 Prospective evaluation of the aetiologies, management and clinical outcomes in patients with pleural effusion Prof. CHAN Ken Ka Pang
2023.338 Comparing N-terminal-proB-type natriuretic peptide (NTproBNP) with other biochemical diagnostic criteria in discriminating heart failure-associated from non-heart failure-associated pleural effusions Prof. CHAN Ken Ka Pang
2023.666 A survey on the practice and interpretation of various diagnostic tests for tuberculous pleuritis among respiratory physicians Prof. CHAN Ken Ka Pang
2023.272 Retrospective study on the protective effects of vaccinations on chronic respiratory diseases Prof. CHAN Ken Ka Pang
2023.110 A pilot study comparing the clinical efficacy and bleeding risk between low dose and standard dose intrapleural tissue plasminogen activator for pleural infection Prof. CHAN Ken Ka Pang
2024.232 Prospective study on detection and prediction of clinically significant pneumothorax after image-guided transthoracic lung biopsy Prof. CHAN Ken Ka Pang
2024.310 Chest Radiograph Research Repository Prof. CHAN Ken Ka Pang
2008.060 Long-term Persistence of Antibodies Induced by Immunization with Human Papillomavirus (HPV) Vaccines Professor Chan Kay Sheung, Paul
2008.200 Prevalence and Genotpye Distribution of Human Papillomaviruses in Hong Kong Women with Abnormal Cervical Cytology, Intraepithelial Neoplasia and Invasive Cervical Cancer Professor Chan Kay Sheung, Paul
2008.243 Age Distribution of Cervical Intraepithelial Neoplasia and Invasive Cervical Cancer in Hong Kong Professor Chan Kay Sheung Paul
2009.029 A Pilot Non-Inferiority Immunogenicity and Safety Open Age-Matched Control Study of A Bivalent Human Papillomavirus Vaccine (Cervarix_) Administered to Females with Systemic Lupus Erythematosus Aged 18-25 Years to Bridge Previous Efficacy Findings on Healthy Females Professor Chan Kay Sheung Paul
2009.631 Comparison of Static and dynamic between Latin dancers and non-Latin dancers above 50 years of age Ms Chan Katie, Ka Po
2017.413 Genome-wide Association of Copy Number Variation in Epithelial Cancer in People with Diabetes Dr. CHAN Katie Kei Hang
陳紀行
2016.581 Whole-genome analysis of copy number variation on Diabetes-related traits among Hong Kong Chinese Dr. CHAN Katie Kei Hang
陳紀行

Page 194 of 254.